0000899243-22-014880.txt : 20220415 0000899243-22-014880.hdr.sgml : 20220415 20220415161548 ACCESSION NUMBER: 0000899243-22-014880 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210616 FILED AS OF DATE: 20220415 DATE AS OF CHANGE: 20220415 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ridloff Elena CENTRAL INDEX KEY: 0001772518 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39460 FILM NUMBER: 22830190 MAIL ADDRESS: STREET 1: C/O ACADIA PHARMACEUTICALS INC. STREET 2: 12830 EL CAMINO REAL, SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kymera Therapeutics, Inc. CENTRAL INDEX KEY: 0001815442 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 812992166 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 ARSENAL YARDS BLVD., SUITE 230 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 857-285-5314 MAIL ADDRESS: STREET 1: 200 ARSENAL YARDS BLVD., SUITE 230 CITY: WATERTOWN STATE: MA ZIP: 02472 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2021-06-16 2021-06-17 0 0001815442 Kymera Therapeutics, Inc. KYMR 0001772518 Ridloff Elena C/O KYMERA THERAPEUTICS, INC. 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472 1 0 0 0 Stock Option (Right to Buy) 49.10 2021-06-16 4 A 0 10459 0.00 A 2031-06-15 Common Stock 10459 10459 D The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 16, 2022 and (ii) the date of the next annual meeting of the Issuer's stockholders. This Amended Form 4 restates the original Form 4 in its entirety. /s/ Bruce Jacobs, as Attorney-in-Fact 2022-04-15